Relevium Drives Top Line Growth for Q1
(firmenpresse) - MONTREAL, QUEBEC -- (Marketwired) -- 11/06/17 -- (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce top line growth for Q1 in anticipation of its interim filings.
What''s New Here?
What Does This Mean?
In M&A, the first six months of integration tends to be the most critical period, as such:
Why Should Investors Care?
First Quarter Disclosure
The Company''s Fiscal Year 2018 started on July 1, 2017 and as such, shareholders can expect to see the full impact of the results from the Bioganix acquisition in Q1 of this new fiscal year, due at the end of this month.
The Company is expecting to hold a conference call for shareholders to discuss the results of Q1, as well as other business developments. The date and time of the conference call is to be announced on a separate press release.
About Relevium Technologies
focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects the Company''s current expectations regarding future events. Forward-looking information is based on several assumptions and is subject to several risks and uncertainties, many of which are beyond the Company''s control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Readers should not place undue reliance on forward- looking statements and forward-looking information and are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake any obligation to update such forward-looking information, whether because of new information, future events or otherwise, except as expressly required by applicable law.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche, President and CEO
RELEVIUM TECHNOLOGIES INC
Contacts:
Edward Ierfino
Investor Relations
Tel: (514) 562-1374
Email:
Website:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 06.11.2017 - 08:09 Uhr
Sprache: Deutsch
News-ID 1527377
Anzahl Zeichen: 3232
contact information:
Contact person:
Town:
MONTREAL, QUEBEC
Phone:
Kategorie:
Medical Devices
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 395 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Relevium Drives Top Line Growth for Q1
"
steht unter der journalistisch-redaktionellen Verantwortung von
Relevium Technologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
